Bertrand Godeau

20.0k total citations · 3 hit papers
229 papers, 9.1k citations indexed

About

Bertrand Godeau is a scholar working on Hematology, Genetics and Pathology and Forensic Medicine. According to data from OpenAlex, Bertrand Godeau has authored 229 papers receiving a total of 9.1k indexed citations (citations by other indexed papers that have themselves been cited), including 174 papers in Hematology, 77 papers in Genetics and 44 papers in Pathology and Forensic Medicine. Recurrent topics in Bertrand Godeau's work include Platelet Disorders and Treatments (145 papers), Blood groups and transfusion (111 papers) and Chronic Lymphocytic Leukemia Research (44 papers). Bertrand Godeau is often cited by papers focused on Platelet Disorders and Treatments (145 papers), Blood groups and transfusion (111 papers) and Chronic Lymphocytic Leukemia Research (44 papers). Bertrand Godeau collaborates with scholars based in France, United States and United Kingdom. Bertrand Godeau's co-authors include Marc Michel, James B. Bussel, Philippe Bierling, Douglas B. Cines, Francesco Rodeghiero, Nichola Cooper, Mehdi Khellaf, Matthieu Mahévas, Terry Gernsheimer and Roberto Stasi and has published in prestigious journals such as The Lancet, Journal of Clinical Investigation and SHILAP Revista de lepidopterología.

In The Last Decade

Bertrand Godeau

214 papers receiving 8.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group

2008 1.9k citations Roberto Stasi, Marc Michel et al. Blood profile →
Thrombocytopenia following Pfizer and Moderna SARS‐CoV‐2 vaccination

2021 270 citations Marc Michel, Bertrand Godeau et al. American Journal of Hematology profile →
Thrombopoietin receptor agonists: ten years later

2019 248 citations Nichola Cooper, Bertrand Godeau et al. profile →

Peers

Countries citing papers authored by Bertrand Godeau

Since Specialization

Citations

This map shows the geographic impact of Bertrand Godeau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bertrand Godeau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bertrand Godeau more than expected).

Fields of papers citing papers by Bertrand Godeau

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bertrand Godeau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bertrand Godeau. The network helps show where Bertrand Godeau may publish in the future.

Co-authorship network of co-authors of Bertrand Godeau

This figure shows the co-authorship network connecting the top 25 collaborators of Bertrand Godeau. A scholar is included among the top collaborators of Bertrand Godeau based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bertrand Godeau. Bertrand Godeau is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Efficacy and safety of dapsone in adult primary immune thrombocytopenia 2025 ·Blood Advances ·(unknown), Guillaume Moulis, (unknown), Sylvain Audia, (unknown), Louis Terriou, Jean‐François Viallard, Brigitte Pan‐Petesch, Bruno Royer, Bernard Bonnotte, Lionel Galicier, O. Lambotte, (unknown), Stéphane Chèze, Mikaël Ebbo, (unknown), (unknown), Laetitia Languille, Matthieu Mahévas, Bertrand Godeau, Florence Canouï‐Poitrine, Marc Michel	0
2	Chronic refractory immune thrombocytopenia in adolescents and young adults 2023 ·British Journal of Haematology ·Alexandra Schifferli, (unknown), Nathalie Aladjidi, Guillaume Moulis, Bertrand Godeau, Thomas Kühne	1
3	FRI531 IgG4 Related Mass -forming Thyroid Disease: Two Case Reports 2023 ·Journal of the Endocrine Society ·(unknown), Céline Droumaguet, (unknown), J. Tran-Van-Nhieu, Émilie Béquignon, Pascal Desgranges, Nicolas Limal, Matthieu Mahévas, Bertrand Godeau	0
4	Clinical significance of antinuclear antibodies in primary immune thrombocytopenia 2023 ·British Journal of Haematology ·Guillaume Moulis, Nathalie Aladjidi, Bertrand Godeau	4
5	Splenectomy for primary immune thrombocytopenia revisited in the era of thrombopoietin receptor agonists: New insights for an old treatment 2021 ·American Journal of Hematology ·Arthur Mageau, Louis Terriou, Mikaël Ebbo, O. Souchaud-Debouverie, Corentin Orvain, J. Graveleau, Jean‐Christophe Lega, M. Ruivard, Jean‐François Viallard, Stéphane Chèze, Antoine Dossier, Bernard Bonnotte, Antoinette Perlat, Delphine Gobert, N. Costedoat‐Chalumeau, Pierre‐Yves Jeandel, (unknown), Marc Michel, Bertrand Godeau, Thibault Comont	22
6	Utilization of intravenous or subcutaneous immunoglobulins in secondary immune deficiency (ULTIMATE): A retrospective multicenter study 2020 ·Clinical Immunology ·Paul Legendre, (unknown), Zora Marjanovic, Marguerite Vignon, Olivier Hermine, Olivier Lortholary, Guillaume Morelle, (unknown), Jean‐Emmanuel Kahn, (unknown), Pascal Chaı̈bi, François Montestruc, Aurore Caumont‐Prim, (unknown), (unknown), Bertrand Godeau, Isabelle Durand‐Zaleski, Luc Mouthon	16
7	Pathogenesis of immune thrombocytopenia 2017 ·Autoimmunity Reviews ·Sylvain Audia, Matthieu Mahévas, M. Samson, Bertrand Godeau, Bernard Bonnotte	254
8	Immune thrombocytopenic purpura: Major progress in knowledge of the pathophysiology and the therapeutic strategy, but still a lot of issues 2014 ·La Presse Médicale ·Bertrand Godeau	13
9	Complications de la splénectomie au cours du purpura thrombopénique immunologique. Revue de la littérature et mesures de prévention 2013 ·La Revue de Médecine Interne ·Matthieu Mahévas, Hélène Coignard-Biehler, Marc Michel, Olivier Lortholary, Bertrand Godeau	1
10	Outcomes 5 years after response to rituximab therapy in children and adults with immune thrombocytopenia 2012 ·Blood ·Vivek Patel, Matthieu Mahévas, Soo Yong Lee, Roberto Stasi, Susanna Cunningham–Rundles, Bertrand Godeau, Julie Kanter, Ellis J. Neufeld, Tillmann Taube, Ugo Ramenghi, Shalini Shenoy, Mary J. Ward, Nino Mihatov, (unknown), Philippe Bierling, Martin Lesser, Nichola Cooper, James B. Bussel	243
11	First Clinical Pilot Study on critical ischemic leg ulcers with Matrix Therapy ReGeneraTing Agent (RGTA®) technology 2011 ·Pascal Desgranges, (unknown), Éric Allaire, Bertrand Godeau, (unknown), J.-P. Becquemin, Denis Barritault	5
12	Pulmonary Artery Thrombosis during Acute Chest Syndrome in Sickle Cell Disease 2011 ·American Journal of Respiratory and Critical Care Medicine ·Armand Mekontso Dessap, Jean‐François Deux, Nour Abidi, Cécile Lavenu‐Bombled, Giovanna Melica, Bertrand Renaud, Bertrand Godeau, Serge Adnot, Laurent Brochard, Christian Brun‐Buisson, Frédéric Galactéros, Alain Rahmouni, Anoosha Habibi, Bernard Maître	90
13	Glomerular Lesions in Patients With Sickle Cell Disease 2010 ·Medicine ·G. Maigné, Sophie Ferlicot, Frederic Galactéros, Xavier Belenfant, Tim Ulinski, Patrick Niaudet, Pierre Ronco, Bertrand Godeau, Antoine Dürrbach, Sabrinel Sahali, Philippe Lang, Olivier Lambotte, Vincent Audard	48
14	Early intermittent noninvasive ventilation for acute chest syndrome in adults with sickle cell disease: a pilot study 2010 ·Intensive Care Medicine ·Muriel Fartoukh, Yannick Lefort, Anoosha Habibi, Dora Bachir, Frédéric Galactéros, Bertrand Godeau, Bernard Maître, Laurent Brochard	32
15	Rituximab efficacy and safety in adult splenectomy candidates with chronic immune thrombocytopenic purpura: results of a prospective multicenter phase 2 study 2008 ·Blood ·Bertrand Godeau, Raphaël Porcher, Olivier Fain, François Lefrère, Pierre Fenaux, Stéphane Chèze, Anne Vekhoff, Marie‐Paule Chauveheid, Jérôme Stirnemann, Lionel Galicier, Emmanuelle Bourgeois, Stéphanie Haïat, Bruno Varet, M Leporrier, T. Papo, Mehdi Khellaf, Marc Michel, Philippe Bierling	184
16	Antiphospholipid antibodies in adults with immune thrombocytopenic purpura 2008 ·British Journal of Haematology ·(unknown), Marc Michel, Mehdi Khellaf, (unknown), L Intrator, Philippe Bierling, Bertrand Godeau	54
17	Induced Sputum versus Bronchoalveolar Lavage during Acute Chest Syndrome in Sickle Cell Disease 2003 ·American Journal of Respiratory and Critical Care Medicine ·Emmanuèle Lechapt, Anoosha Habibi, Dora Bachir, Frédéric Galactéros, Annette Schaeffer, Dominique Desvaux, Laurent Brochard, Bruno Housset, Bertrand Godeau, Bernard Maître	27
18	Acute Chest Syndrome in Adults With Sickle Cell Disease 2000 ·CHEST Journal ·Bernard Maître, Anoosha Habibi, Françoise Roudot‐Thoraval, Dora Bachir, D Belghiti, Frédéric Galactéros, Bertrand Godeau	88
19	Pulmonary Hypertension in POEMS Syndrome: A New Feature Mediated by Cytokines 1998 ·American Journal of Respiratory and Critical Care Medicine ·Philippe Lesprit, Bertrand Godeau, François‐Jérôme Authier, Martin Soubrier, Mathieu Zuber, C. Larroche, Jean‐Paul Viard, B. Wechsler, Romain K. Gherardi	112
20	Purpura thrombopénique idiopathique 1995 ·Hématologie ·H Rochant, Philippe Bierling, (unknown), (unknown), James B. Bussel, Bertrand Godeau	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact